What's New on the FDA Drugs Site

June 1, 2011

FDA Drug Safety Podcast for Healthcare Professionals: Safety Review of possible increased risk of blood clots with birth control pills containing drospirenone
Drug Shortages: Current Drug Shortages: Norepinephrine Bitartrate Injection (updated)
Manual of Policies and Procedures (MAPPs) Management of CDER Pharmacology/Toxicology Coordinating Committee and Its Associated Subcommittees and Working Groups (PDF - 119KB)
National Drug Code Directory (updated)
New and Generic Drug Approvals

June 1, 2011

Donepezil Hydrochloride Tablets, Matrix Laboratories Ltd., Approval
Donepezil Hydrochloride Tablets, Cipla Ltd., Approval
Donepezil Hydrochloride Tablets, Wockhardt Ltd., Approval
Donepezil Hydrochloride Tablets, Roxane Laboratories, Inc., Approval
Donepezil Hydrochloride Tablets, Sandoz Inc., Approval
Donepezil Hydrochloride Tablets, Sun Pharmaceutical Industries Ltd., Approval
Donepezil Hydrochloride Tablets, Huahai US Inc., Approval
Donepezil Hydrochloride Tablets, Hikma Pharmaceuticals, Approval
Donepezil Hydrochloride Tablets, Actavis Pharma, Approval
Donepezil Hydrochloride Tablets, Torrent Pharmaceuticals Ltd., Approval
Donepezil Hydrochloride Tablets, Pliva Hrvatska, Approval
Donepezil Hydrochloride Tablets, Jubilant Life Sciences Ltd., Approval
Donepezil Hydrochloride Tablets, Teva Pharmaceuticals, Approval
Donepezil Hydrochloride Tablets, Dr. Reddy’s Laboratories Ltd., Approval
Donepezil Hydrochloride Tablets, Aurobindo Pharma, Approval